PL365072A1 - Azole compounds as therapeutic agents for fungal infections - Google Patents

Azole compounds as therapeutic agents for fungal infections

Info

Publication number
PL365072A1
PL365072A1 PL01365072A PL36507201A PL365072A1 PL 365072 A1 PL365072 A1 PL 365072A1 PL 01365072 A PL01365072 A PL 01365072A PL 36507201 A PL36507201 A PL 36507201A PL 365072 A1 PL365072 A1 PL 365072A1
Authority
PL
Poland
Prior art keywords
therapeutic agents
fungal infections
azole compounds
azole
compounds
Prior art date
Application number
PL01365072A
Other languages
Polish (pl)
Inventor
Ashwani Kumar Verma
Sudershan K. Arora
Jasbir Singh Arora
Ashok Rattan
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN198DE2000 external-priority patent/IN191188B/en
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL365072A1 publication Critical patent/PL365072A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL01365072A 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections PL365072A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN198DE2000 IN191188B (en) 2000-03-07 2000-03-07
US09/575,578 US6670363B1 (en) 2000-03-07 2000-05-22 Azole compounds as therapeutic agents for fungal infections
PCT/IB2001/000300 WO2001066551A2 (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Publications (1)

Publication Number Publication Date
PL365072A1 true PL365072A1 (en) 2004-12-27

Family

ID=26324879

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365072A PL365072A1 (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Country Status (8)

Country Link
EP (1) EP1278755A2 (en)
JP (1) JP2004501867A (en)
AU (1) AU3402301A (en)
CA (1) CA2402345A1 (en)
NZ (1) NZ521241A (en)
PL (1) PL365072A1 (en)
RU (1) RU2002126272A (en)
WO (1) WO2001066551A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002218505A1 (en) * 2000-11-30 2002-06-11 Senju Pharmaceutical Co. Ltd. Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis
HUP0400725A2 (en) 2000-12-26 2004-07-28 Ranbaxy Laboratories Limited Substituted 1,2,4-triazole-3(2h,4h)-thione derivatives, process for their preparation and pharmaceutical compositions containing them
WO2002060446A1 (en) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
IN192526B (en) * 2001-09-25 2004-04-24 Ranbaxy Lab
WO2004018485A1 (en) * 2002-08-26 2004-03-04 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
EP1413301A1 (en) * 2002-10-24 2004-04-28 Bayer CropScience SA Antifungal medicaments comprising arylamidine derivatives
CA2618653A1 (en) 2005-08-12 2007-02-22 Takeda Pharmaceutical Company Limited Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
BR112013033239A2 (en) 2011-06-22 2016-09-06 Vyome Biosciences atifungic and antibacterial-based conjugate prodrugs
CN102617494B (en) * 2012-03-15 2014-10-29 南京工业大学 Triazole compound containing vinyl ether structure and preparation method and application thereof
EA201592236A1 (en) 2013-06-04 2016-06-30 Вайом Байосайнсиз Пвт. Лтд. PARTICULATED COATINGS AND COMPOSITIONS INCLUDING SUCH PARTICLES
WO2015114666A2 (en) 2014-01-29 2015-08-06 Vyome Biosciences Pvt. Ltd. Treatments for resistant acne
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2018060070A1 (en) 2016-09-29 2018-04-05 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218017B (en) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Also Published As

Publication number Publication date
NZ521241A (en) 2004-02-27
WO2001066551A2 (en) 2001-09-13
AU3402301A (en) 2001-09-17
RU2002126272A (en) 2004-08-10
CA2402345A1 (en) 2001-09-13
JP2004501867A (en) 2004-01-22
WO2001066551A8 (en) 2003-06-26
EP1278755A2 (en) 2003-01-29
WO2001066551A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002221239A1 (en) Therapeutic benzimidazole compounds
IL176151A0 (en) Endoparasiticidal agents for topical application
EP1387680A4 (en) Benzimidazole derivatives as therapeutic agents
HK1057702A1 (en) Triazole compounds useful as protein kinase inhibitors
AU2001230426A1 (en) Therapeutic morpholino-substituted compounds
IL153787A0 (en) Imidazole derivatives
IL148719A0 (en) Kinase inhibitors as therapeutic agents
EP1432420A4 (en) Benzimidazolidinone derivatives as muscarinic agents
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
IL160851A0 (en) Thiopene-and thiazolesulfonamides as antineoplastic agents
IL159742A0 (en) Azole derivatives useful as insecticide
PL365072A1 (en) Azole compounds as therapeutic agents for fungal infections
AU2002334270A1 (en) Azole derivatives as antifungal agents
GB0118407D0 (en) Oxazolidinone derivatives as antibacterial agents
AU2002253456A8 (en) Azole derivatives as antifungal agents
AU1495802A (en) Fungicidal formulation
GB0106631D0 (en) Pharmaceutically active compounds
SI1261588T1 (en) IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
AU2003258983A8 (en) Combinations for the treatment of fungal infections
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
PL362051A1 (en) Azole compounds as anti-fungals agents
EP1412337A4 (en) Azole compounds as anti-fungal agents
GB2360705B (en) Anti fungal formulation
AU2002345264A1 (en) Azole compounds as anti-fungal agents
GB0001715D0 (en) Treatment for fungal infections

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)